These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9547438)

  • 1. Clinical trials for prevention of congestive heart failure: from retrospective analysis to prospective hope.
    Hirsch AT
    J Card Fail; 1997 Dec; 3(4):255-6. PubMed ID: 9547438
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease.
    Kjekshus J; Pedersen TR; Olsson AG; Faergeman O; Pyörälä K
    J Card Fail; 1997 Dec; 3(4):249-54. PubMed ID: 9547437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of simvastin in cholesterol lowering.
    Farmer JA
    Curr Atheroscler Rep; 2003 Mar; 5(2):93-4. PubMed ID: 12573191
    [No Abstract]   [Full Text] [Related]  

  • 4. [Simvastatin inhibits coronary heart disease progression and prolongs life expectancy].
    Z Kardiol; 1998 Mar; 87(3 Suppl Simvastati):1-4. PubMed ID: 9569494
    [No Abstract]   [Full Text] [Related]  

  • 5. Lowering cholesterol in patients with coronary heart disease: are we ready yet?
    Barrett-Connor E
    Circulation; 1997 Dec; 96(12):4124-5. PubMed ID: 9416875
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins in the prevention of coronary heart disease.
    Williamson DR; Pharand C
    Pharmacotherapy; 1998; 18(2):242-54. PubMed ID: 9545143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl].
    MMW Fortschr Med; 2008 Jun; 150(23):39. PubMed ID: 18575369
    [No Abstract]   [Full Text] [Related]  

  • 8. [Even at LDL cholesterol 100mg/dl. "Every coronary disease patient has to receive a statin"].
    MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963997
    [No Abstract]   [Full Text] [Related]  

  • 9. [Statin is indicated to all patients with high risk of complications of coronary heart disease irrespective of the level of low density lipoprotein cholesterol. Results of HPS].
    Gratsianskiĭ NA
    Kardiologiia; 2002; 42(2):84-5. PubMed ID: 12494213
    [No Abstract]   [Full Text] [Related]  

  • 10. Simvastatin.
    Nurs Times; 2005 May 17-23; 101(20):35. PubMed ID: 15918459
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholestanol and survival with simvastatin. More data are needed.
    Wallis EJ; Williamson R; Ramsay LE; Yeo WW; Jackson PR
    BMJ; 1998 Oct; 317(7167):1252-3. PubMed ID: 9794879
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy and clinical trials.
    Sussekov AV
    Curr Opin Lipidol; 1997 Oct; 8(5):U73-5. PubMed ID: 9335964
    [No Abstract]   [Full Text] [Related]  

  • 13. [4S [Scandinavian Simvastatin Survival Study]].
    Koizumi J; Yoshida I
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():410-5. PubMed ID: 11347105
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on the MRC/BHF Heart Protection Study.
    Mikhail N
    Lancet; 2003 Aug; 362(9385):744; author reply 744-5. PubMed ID: 12957101
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.
    Pedersen TR
    Am J Cardiol; 1998 Nov; 82(10B):53T-56T. PubMed ID: 9860376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
    Girman CJ; Rhodes T; Mercuri M; Pyörälä K; Kjekshus J; Pedersen TR; Beere PA; Gotto AM; Clearfield M;
    Am J Cardiol; 2004 Jan; 93(2):136-41. PubMed ID: 14715336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding indications of statins; implications of the Heart Protection Study.
    Salam AM
    Expert Opin Investig Drugs; 2003 Mar; 12(3):509-13. PubMed ID: 12605572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients.
    Tunceli K; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tomassini JE; Foody JM
    J Clin Lipidol; 2010; 4(6):491-500. PubMed ID: 21122696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell adhesion molecules, simvastatin and hormone replacement therapy, in coronary artery disease.
    Rehnqvist N
    Eur Heart J; 2000 Jun; 21(12):963-4. PubMed ID: 10901506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.